Fukuoka, Kurume, Japan Clinical Trials

A listing of Fukuoka, Kurume, Japan clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
Safety and Pharmacokinetics of REGN2810 (Anti-PD-1) in Japanese Patients With Advanced Malignancies

The primary objective of the study is to assess the safety, tolerability, and Pharmacokinetics (PK) of REGN2810 in Japanese patients with advanced malignancies. The secondary objective of the study is to assess the immunogenicity of REGN2810.

ipilimumab
Kurume University Hospital
 (0.6 away) Contact site
  • 15 views
  • 24 Jan, 2021
  • +22 other locations
A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor

The primary purpose of the study is to evaluate safety and tolerability and to determine recommended Phase 2 dose (RP2D) of E7389-LF in combination with nivolumab in Phase 1b part, and to evaluate objective response rate (ORR) of E7389-LF and nivolumab using RP2D in Phase 2 part in each tumor …

Eisai Trial Site #4
 (0.0 away) Contact site
  • 2 views
  • 06 Apr, 2021
  • +16 other locations
ONO-4538 Phase II Rollover Study (ONO-4538-98)

This study is intended to confirm the long-term safety of ONO-4538 in pan-tumor participants being treated with ONO-4538 monotherapy in clinical trials.

Fukuoka Clinical Site1
 (0.0 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +13 other locations
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

This is a randomized, open-label, multi-center, global, Phase III study to assess the efficacy and safety of durvalumab plus tremelimumab combination therapy and durvalumab monotherapy versus sorafenib in the treatment of patients with no prior systemic therapy for unresectable HCC. The patients cannot be eligible for locoregional therapy.

cancer
sorafenib
durvalumab
liver cancer
systemic therapy
Research Site
 (0.0 away) Contact site
  • 272 views
  • 10 Jun, 2021
  • +247 other locations
A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies

The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and severely active Crohn's disease (CD).

immunosuppressive agents
crohn's disease
corticosteroids
conventional treatment
mucosal inflammation
Kurume University Hospital /ID# 166012
 (0.6 away) Contact site
  • 824 views
  • 02 Jun, 2021
  • +730 other locations
A Study to Evaluate the Efficacy and Safety of Brivaracetam in Study Participants (>=16 to 80 Years of Age) With Epilepsy

The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) compared to placebo (PBO) as adjunctive treatment in subjects (>=16 to 80 years of age) with partial seizures with or without secondary generalization despite current treatment with 1 or 2 concomitant antiepileptic drugs (AEDs) and to assess …

vagus nerve stimulation
partial seizure
adjunctive treatment
seizure
brivaracetam
Ep0083 126
 (0.0 away) Contact site
  • 840 views
  • 19 Jun, 2021
  • +108 other locations
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Open label study to evaluate tafamidis for the treatment of transthyretin cardiomyopathy

Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +144 other locations
Study of Amivantamab a Human Bispecific EGFR and cMet Antibody in Participants With Advanced Non-Small Cell Lung Cancer

The purpose of study is to evaluate the safety, pharmacokinetics, and preliminary efficacy of Amivantamab as a monotherapy and in combination with lazertinib, and to determine the recommended Phase 2 dose (RP2D) (monotherapy), recommended Phase 2 combination dose (RP2CD) (combination therapy), and to determine recommended Phase 2 Dose (RP2q3W) with …

platinum-based chemotherapy
measurable disease
kinase inhibitor
cancer chemotherapy
lung carcinoma
Kurume University Hospital
 (0.6 away) Contact site
  • 0 views
  • 24 May, 2021
  • +105 other locations
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

This study is designed to evaluate the long-term efficacy and safety of mirikizumab in participants with moderately to severely active ulcerative colitis (UC).

mirikizumab
Yukinoseibokai St. Mary's Hospital
 (1.0 away) Contact site
  • 257 views
  • 17 Jun, 2021
  • +607 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

infarct
stemi
myocardial infarction
percutaneous coronary intervention
arterial disease
3920110 - Kurume University Hospital
 (0.6 away) Contact site
  • 1118 views
  • 18 Jun, 2021
  • +3422 other locations